Cognito Therapeutics
Cognito Therapeutics
Claim
Cognito Therapeutics is a clinical-stage company leading the development of a new class of disease-modifying digital therapeutics to treat neurodegenerative disorders including Alzheimer’s disease. The company’s licensed proprietary neuromodulation platform technology is a non-invasive, neurostimulation therapy utilizing visual and auditory stimulation to treat neurodegenerative diseases.Cognito Therapeutics is a clinical-stage company leading the development of a new class of disease-m Show More
Alpha Score
$ 263.00 M
Alpha Score
74.5
Predictions
Overview
Team
Financials- Partnerships
Relationships
Locations
Competitors
Comparison
News
Product
Regulatory
Clinical
Patent
Publications
Notes
0and0